Related Experiment Video
Updated: Feb 2, 2026

Author Spotlight: Expanding the Scope of Multiplex Immunoassays for Lyme Borreliosis Diagnostics and Pathogen Research
Published on: July 14, 2023
Development and validation of a robust multiplex serological assay to quantify antibodies specific to pertussis
Gowrisankar Rajam1, George Carlone1, Ellie Kim1
1Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA.
Insights
A new multiplex assay quantifies antibodies to five pertussis antigens simultaneously. This method, the microsphere based multiplex antibody capture assay (MMACA), is sensitive, specific, and requires minimal sample volume, aiding pediatric pertussis research.
Area of Science:
- Immunology
- Vaccinology
- Biotechnology
Background:
- Pertussis remains a significant public health concern despite widespread vaccination.
- Current methods for quantifying antibodies against Bordetella pertussis (Bp) antigens are laborious and require large sample volumes.
- Existing assays are challenging for pediatric samples due to limited serum availability.
Purpose of the Study:
- To develop and validate a novel assay for simultaneous quantification of antibodies against multiple Bp antigens.
- To overcome the limitations of traditional ELISA for pediatric pertussis serology.
- To establish a sensitive, specific, and robust method for Bp antibody detection.
Main Methods:
- Development of a microsphere based multiplex antibody capture assay (MMACA) for a 5-plex quantification.
- Assay included pertussis toxin, pertactin, filamentous hemagglutinin, fimbrial antigens 2/3, and adenylate cyclase toxin.
- Utilized a calibrated reference standard, QC reagents, and SAS-based data analysis.
Main Results:
- MMACA demonstrated excellent standard curve fit (R² ≥0.99) and acceptable precision (median CV 16.0%-22.8%).
- The assay showed high accuracy (1.9%-23.8% %E) and linearity (slopes 0.93-1.02).
- Low serum volume (5µL), rapid turnaround time (<3h assay, <1min data), and minimal lot-to-lot variation (<12.3%) were achieved.
Conclusions:
- MMACA is a validated, sensitive, specific, robust, and rugged method for simultaneous anti-Bp antibody quantification.
- The assay is suitable for use with serum, plasma, and dried blood spots (DBS).
- MMACA offers a significant advancement for pertussis serological studies, especially in resource-limited settings and pediatric populations.
Abstract:
Despite wide spread vaccination, the public health burden of pertussis remains substantial. Current acellular pertussis vaccines comprise upto five Bordetella pertussis (Bp) antigens. Performing an ELISA to quantify antibody for each antigen is laborious and challenging to apply to pediatric samples where serum volume may be limited. We developed a microsphere based multiplex antibody capture assay (MMACA) to quantify antibodies to five pertussis antigens; pertussis toxin, pertactin, filamentous hemagglutinin and fimbrial antigens 2/3, and adenylate cyclase toxin in a single reaction (5-plex) with a calibrated reference standard, QC reagents and SAS® based data analysis program. The goodness of fit (R2) of the standard curves for five analytes was ≥0.99, LLOQ 0.04-0.15 IU or AU/mL, accuracy 1.9%-23.8% (%E), dilutional linearity slopes 0.93-1.02 and regression coefficients r2 = 0.91-0.99. MMACA had acceptable precision within a median CV of 16.0%-22.8%. Critical reagents, antigen conjugated microsphere and reporter antibody exhibited acceptable (<12.3%) lot-lot variation. MMACA can be completed in <3 h, requires low serum volume (5microL/multiplex assay) and has fast data turnaround time (<1 min). MMACA has been successfully developed and validated as a sensitive, specific, robust and rugged method suitable for simultaneous quantification of anti-Bp antibodies in serum, plasma and DBS.
More Related Videos
09:12A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Published on: June 15, 2018
06:34An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers
Published on: December 1, 2017
Related Concept Videos
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Reliability and Validity
In Vitro Drug Release Testing: Overview, Development and Validation
Quantifying Work
Data Validation
Key parameters for method validation include:
Data Validation
Nursing assessment guides are generally based on holistic models rather than medical...